A. Lindahl

发表

Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women

H. Lennernäs, A. Ungell, L. Knutson, 1997, Pharmaceutical Research.

Is the full potential of the biopharmaceutics classification system reached?

Christel A. S. Bergström, Christel A S Bergström, A. Lindahl, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?

A. Lindahl, A. van Peer, T. Flanagan, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development

Anna Nordmark, A. Lindahl, Anders Lindahl, 2011, Drug development and industrial pharmacy.

Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory Perspectives

M. Bolger, B. Hens, T. Heimbach, 2020, Pharmaceutical Research.

Surface Activity and Concentration Dependent Intestinal Permeability in the Rat

H. Lennernäs, A. Ungell, A. Lindahl, 2004, Pharmaceutical Research.

Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms

H. Lennernäs, U. Fagerholm, A. Lindahl, 1997, The Journal of pharmacy and pharmacology.

No evidence for the involvement of the multidrug resistance-associated protein and/or the monocarboxylic acid transporter in the intestinal transport of fluvastatin in rats

H. Lennernäs, A. Ungell, A. Lindahl, 2000, AAPS PharmSci.

In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.

Talia Flanagan, Clive G. Wilson, Mai Anh Nguyen, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Is the Jejunal Permeability in Rats Age-Dependent?

H. Lennernäs, A. Ungell, A. Lindahl, 1997, Pharmaceutical Research.

Six years of progress in the oral biopharmaceutics area - a summary from the IMI OrBiTo project.

H Lennernäs, A Lindahl, E Sjögren, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nature of the C-Cluster in Ni-Containing Carbon Monoxide Dehydrogenases

A. Lindahl, P. Ludden, E. Münck, 1996 .

Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.

H Lennernäs, A Lindahl, B Abrahamsson, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Concentration‐ and Region‐dependent Intestinal Permeability of Fluvastatin in the Rat

H. Lennernäs, A. Lindahl, R. Sandström, 1998, The Journal of pharmacy and pharmacology.

A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans.

H. Lennernäs, H. Kristensen, L. Knutson, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

Flora Musuamba Tshinanu, E. Manolis, A. Lindahl, 2023, CPT: pharmacometrics & systems pharmacology.

Current status and future opportunities for incorporation of dissolution data in pbpk modeling for pharmaceutical development and regulatory applications: orbito consortium commentary.

Filippos Kesisoglou, Tycho Heimbach, Xavier Pepin, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.

H Lennernäs, A Lindahl, A Van Peer, 2017, Molecular pharmaceutics.

Jejunal permeability and hepatic extraction of fluvastatin in humans

H Lennernäs, B Abrahamsson, H. Lennernäs, 1996, Clinical pharmacology and therapeutics.

Regional intestinal absorption and biliary excretion of fluvastatin in the rat: possible involvement of mrp2.

H. Lennernäs, U. Bredberg, A. Ungell, 2004, Molecular pharmaceutics.

Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory Perspectives

M. Bolger, B. Hens, T. Heimbach, 2020, Pharmaceutical Research.

Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans.

Bertil Abrahamsson, Christer Tannergren, B. Abrahamsson, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured GFR markers in Europe.

A. Grzegorczyk, L. Jacobsson, A. Lindahl, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clive G. Wilson, A. Peer, H. Lennernäs, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report

Megerle L. Scherholz, Cordula Stillhart, Sumit Arora, 2024, Molecular pharmaceutics.

A. Lindahl, A. Nordmark, K. Sigfridsson, 2011, Drug development and industrial pharmacy.